ZOLL to Host First Dubai Cardiac Arrest Symposium
|
By HospiMedica International staff writers Posted on 11 Feb 2014 |
|
ZOLL Medical Corporation (Chelmsford, MA, USA), a leading manufacturer of medical devices and related software solutions, will host the first Dubai Cardiac Arrest Symposium together with the Emirates Cardiac Society (Abu Dhabi, UAE).
The symposium, which will take place on February 22, 2014, at the Crowne Plaza Dubai (UAE), will focus on addressing ways to improve outcomes in resuscitation in the Gulf and Arab states, and is expected to attract an audience of cardiologists, emergency physicians, anesthesiologists, and resuscitation officers and directors from throughout the Middle East. The opening speaker is the chairman of the event, Alawi Alsheikh-Ali, MD, President of ECS, who will present “Cardiac arrest in the Gulf—Where are the data?”
In addition, leading experts in cardiology from around the world will address related topics such as cardiopulmonary resuscitation (CPR) awareness; high-quality CPR in relationship to success; pre-hospital cardiac arrest management from pavement to percutaneous coronary intervention (PCI); and ZOLL AutoPulse-facilitated PCI for out-of-hospital cardiac arrest. A sudden cardiac arrest survivor will conclude the symposium with a presentation entitled “I shouldn’t be alive.”
“Sudden cardiac arrest is the leading cause of unexpected death around the world, killing as many as one million people annually,” said Jonathan A. Rennert, president of ZOLL. “Yet many of these deaths are potentially preventable when high-quality CPR is delivered. Advancing resuscitation care could improve survival from this major worldwide health problem.”
The Emirates Cardiac Society is a network of all cardiologists in the UAE that works under the umbrella of the Emirates Medical Association (EMA; Dubai, UAE). Its mission is to educate public and healthcare professionals in reducing the burden of cardiovascular disease in the UAE. The ECS promotes health education within the community, raises awareness of health issues among the general population, and establishes strong partnerships with national and international health agencies and establishments.
Related Links:
ZOLL Medical Corporation
Emirates Cardiac Society
Emirates Medical Association
The symposium, which will take place on February 22, 2014, at the Crowne Plaza Dubai (UAE), will focus on addressing ways to improve outcomes in resuscitation in the Gulf and Arab states, and is expected to attract an audience of cardiologists, emergency physicians, anesthesiologists, and resuscitation officers and directors from throughout the Middle East. The opening speaker is the chairman of the event, Alawi Alsheikh-Ali, MD, President of ECS, who will present “Cardiac arrest in the Gulf—Where are the data?”
In addition, leading experts in cardiology from around the world will address related topics such as cardiopulmonary resuscitation (CPR) awareness; high-quality CPR in relationship to success; pre-hospital cardiac arrest management from pavement to percutaneous coronary intervention (PCI); and ZOLL AutoPulse-facilitated PCI for out-of-hospital cardiac arrest. A sudden cardiac arrest survivor will conclude the symposium with a presentation entitled “I shouldn’t be alive.”
“Sudden cardiac arrest is the leading cause of unexpected death around the world, killing as many as one million people annually,” said Jonathan A. Rennert, president of ZOLL. “Yet many of these deaths are potentially preventable when high-quality CPR is delivered. Advancing resuscitation care could improve survival from this major worldwide health problem.”
The Emirates Cardiac Society is a network of all cardiologists in the UAE that works under the umbrella of the Emirates Medical Association (EMA; Dubai, UAE). Its mission is to educate public and healthcare professionals in reducing the burden of cardiovascular disease in the UAE. The ECS promotes health education within the community, raises awareness of health issues among the general population, and establishes strong partnerships with national and international health agencies and establishments.
Related Links:
ZOLL Medical Corporation
Emirates Cardiac Society
Emirates Medical Association
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Mammography System (Analog)
MAM VENUS
New
Ureteral Dilatation Balloon
Dornier Equinox
Latest Business News
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- Boston Scientific Acquires Medical Device Company SoniVie
- 2026 World Hospital Congress to be Held in Seoul
- Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
- Philips and Mass General Brigham Collaborate on Improving Patient Care with Live AI-Powered Insights
- Arab Health 2025 Celebrates Landmark 50th Edition
- Boston Scientific Acquires Medical Device Company Intera Oncology
- MEDICA 2024 to Highlight Hot Topics of MedTech Industry
- Start-Ups To Once Again Play Starring Role at MEDICA 2024
- Boston Scientific to Acquire AFib Ablation Company Cortex
- Hologic Acquires Gynesonics to Strengthen Existing Gynecological Surgical Business
- Smith+Nephew and JointVue Partner on Ultrasound Preoperative Planning in Robotics-Assisted Surgery
- Stryker Completes Acquisition of NICO Corporation
Channels
Surgical Techniques
view channel
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read more
New Surgical Microscope Offers Precise 3D Imaging Using 48 Tiny Cameras
Surgeons have long relied on stereoscopic microscopes to gain depth perception during delicate procedures, but this method has limitations. While these microscopes provide a sense of three-dimensionality,... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
